7396 TR for Sale
Low MOQ Synthetic 2S10 Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR5Top Quality Peptides Lyophilized Powder Tirzepatide Fitness and Weight Loss
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
5mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
F410 Low MOQ Synthetic Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
LL3710 Low MOQ Synthetic Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
L 375 Low MOQ Synthetic Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Products You May Be Interested in
TR20 | Certified Block | 99% | | Powder Peptide | Shipped from Chinese Warehouse
-
CAS No.:
1415456-99-3
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
20mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TA10 Low MOQ Synthetic Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TA5 Low MOQ Synthetic Peptide Powder High Assay Raw Material For Laboratory Research
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
5mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TR40high-quality products, available in stock in the warehouse, fast and safe delivery,99% high-purity, on-time shipment
-
CAS No.:
1415456-99-3
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
40mg*/vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
5AD offers rapid delivery, high-purity dry powder, directly supplied by the factory, and is used for weight loss.
-
Price:
$100/MT FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
5mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
- Finding TR for sale in large quantity of choices all on www.echemi.com. The suppliers of 7396 TR on the search result are been verified by the accurate information of each one. Accurate information is the prerequisite of transaction. Buy TR with 70000+ customers on ECHEMI and make orders now.
- TR 2026000-20-2 from ECHEMI are quality guaranteed. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. TR will reach global regulation and requirement of various regions. Customized services of TR will provided to customers on ECHEMI.
- We are providing better products and services of TR with fair price and reasonable deal. Registered member can enjoy more services of TR on with market price and insights, global news, trade data and so on. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying TR.
- •Cost-Driven Acrylonitrile Market Halts Decline and Stabilizes
- •In August, the domestic propylene oxide market showed an upward trend in price levels
- •Business Society’s Market Outlook for n-Butanol on September 4, 2026: Fluctuating Trend
- •September 4, 2026 DMF Market View in China: Relatively Strong
- •Business Society’s September 4, 2026 Melamine Market Outlook: Fluctuating Trend